Pediatric solid tumor genomics and developmental pliancy

• Published in: Oncogene Vol. 34; no. 41; pp. 5207 - 5215
• Main Authors: Chen, X, Pappo, A, Dyer, M A
• Format: Journal Article
• Language: English
• Published: London Nature Publishing Group UK 08.10.2015; Nature Publishing Group
• Subjects: 45/23; 631/67/69; Apoptosis; Cancer; Cancer in children; Cell Biology; Child; Development and progression; Disease susceptibility; Epigenesis, Genetic; Gene Expression Regulation, Neoplastic; Genes, Neoplasm; Genetic aspects; Genetic research; Genomics; Human Genetics; Humans; Internal Medicine; Medicine; Medicine & Public Health; Mutation; Neoplasms - genetics; Neoplasms - pathology; Oncology; Oncology, Experimental; Pediatrics; Review; Tumors
• ISSN: 0950-9232; 1476-5594
• DOI: 10.1038/onc.2014.474

Pediatric solid tumors are remarkably diverse in their cellular origins, developmental timing and clinical features. Over the last 5 years, there have been significant advances in our understanding of the genetic lesions that contribute to the initiation and progression of pediatric solid tumors. To date, over 1000 pediatric solid tumors have been analyzed by Next-Generation Sequencing. These genomic data provide the foundation to launch new research efforts to address one of the fundamental questions in cancer biology—why are some cells more susceptible to malignant transformation by particular genetic lesions at discrete developmental stages than others? Because of their developmental, molecular, cellular and genetic diversity, pediatric solid tumors provide an ideal platform to begin to answer this question. In this review, we highlight the diversity of pediatric solid tumors and provide a new framework for studying the cellular and developmental origins of pediatric cancer. We also introduce a new unifying concept called cellular pliancy as a possible explanation for susceptibility to cancer and the developmental origins of pediatric solid tumors.